{
  "url": "https://www.webmd.com/drugs/updates/new-oral-option-children-itp-droptelet",
  "title": "New Oral Option for Children With Low Platelet Counts: Doptelet",
  "slug": "new-oral-option-children-itp-droptelet",
  "published_date": "2025-07-28",
  "first_letter": "N",
  "author": "Joyani Das, PhD",
  "medically_reviewed_by": "Mary  Windle, PharmD",
  "read_time": "3 min read",
  "sections": [
    {
      "heading": "What Is Doptelet, and Why Does It Matter?",
      "content": [
        "Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, it is now also approved by the FDA for children aged 1 year or older with chronic immune thrombocytopenia (ITP) who haven’t gotten good responses from earlier treatments. ITP is a condition where the immune system mistakenly destroys platelets, leading to easy bruising, bleeding, and fatigue. ITP affects about 5 out of every 100,000 children each year. It can also limit children’s physical activity due to the risk of bleeding.",
        "Doptelet belongs to a group of medicines called thrombopoietin receptor agonists (TPO-RAs). These work by mimicking a natural protein that helps the body make more platelets. This approval is important because it offers a pill-based option and does not require injections. Doptelet can be taken with food and doesn’t require any special diet changes.",
        "There is no permanent cure for ITP, and symptoms can return even after treatment. Having more options like Doptelet may help doctors better manage this condition in children who need long-term care."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, it is now also approved by the FDA for children aged 1 year or older with chronic immune thrombocytopenia (ITP) who haven’t gotten good responses from earlier treatments. ITP is a condition where the immune system mistakenly destroys platelets, leading to easy bruising, bleeding, and fatigue. ITP affects about 5 out of every 100,000 children each year. It can also limit children’s physical activity due to the risk of bleeding.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doptelet belongs to a group of medicines called thrombopoietin receptor agonists (TPO-RAs). These work by mimicking a natural protein that helps the body make more platelets. This approval is important because it offers a pill-based option and does not require injections. Doptelet can be taken with food and doesn’t require any special diet changes.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "There is no permanent cure for ITP, and symptoms can return even after treatment. Having more options like Doptelet may help doctors better manage this condition in children who need long-term care.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Why Was It Approved?",
      "content": [
        "Doptelet was approved because studies showed it helped raise platelet counts in both children and adults with chronic ITP and in adults with liver disease who needed a procedure.",
        "Doptelet was studied in 75 children with ITP who had not improved with earlier treatments. The children were randomly selected to receive either Doptelet or a placebo. Among those taking Doptelet, about 28% reached a stable platelet count without needing additional treatment, and 81% showed improved platelet levels. By the eighth day of treatment, more than half of the children had platelet levels above the target range. In contrast, none of the children receiving the placebo showed similar improvements at any point during the study.",
        "The most common side effects reported during the study were mild and included viral infections, cough, sore throat, and fever. Serious side effects are rare, and no deaths or major bleeding events were reported during the studies."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet was approved because studies showed it helped raise platelet counts in both children and adults with chronic ITP and in adults with liver disease who needed a procedure.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doptelet was studied in 75 children with ITP who had not improved with earlier treatments. The children were randomly selected to receive either Doptelet or a placebo. Among those taking Doptelet, about 28% reached a stable platelet count without needing additional treatment, and 81% showed improved platelet levels. By the eighth day of treatment, more than half of the children had platelet levels above the target range. In contrast, none of the children receiving the placebo showed similar improvements at any point during the study.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The most common side effects reported during the study were mild and included viral infections, cough, sore throat, and fever. Serious side effects are rare, and no deaths or major bleeding events were reported during the studies.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What Is Doptelet, and Why Does It Matter?",
      "content": [
        "Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, it is now also approved by the FDA for children aged 1 year or older with chronic immune thrombocytopenia (ITP) who haven’t gotten good responses from earlier treatments. ITP is a condition where the immune system mistakenly destroys platelets, leading to easy bruising, bleeding, and fatigue. ITP affects about 5 out of every 100,000 children each year. It can also limit children’s physical activity due to the risk of bleeding.",
        "Doptelet belongs to a group of medicines called thrombopoietin receptor agonists (TPO-RAs). These work by mimicking a natural protein that helps the body make more platelets. This approval is important because it offers a pill-based option and does not require injections. Doptelet can be taken with food and doesn’t require any special diet changes.",
        "There is no permanent cure for ITP, and symptoms can return even after treatment. Having more options like Doptelet may help doctors better manage this condition in children who need long-term care."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, it is now also approved by the FDA for children aged 1 year or older with chronic immune thrombocytopenia (ITP) who haven’t gotten good responses from earlier treatments. ITP is a condition where the immune system mistakenly destroys platelets, leading to easy bruising, bleeding, and fatigue. ITP affects about 5 out of every 100,000 children each year. It can also limit children’s physical activity due to the risk of bleeding.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doptelet belongs to a group of medicines called thrombopoietin receptor agonists (TPO-RAs). These work by mimicking a natural protein that helps the body make more platelets. This approval is important because it offers a pill-based option and does not require injections. Doptelet can be taken with food and doesn’t require any special diet changes.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "There is no permanent cure for ITP, and symptoms can return even after treatment. Having more options like Doptelet may help doctors better manage this condition in children who need long-term care.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "Why Was It Approved?",
      "content": [
        "Doptelet was approved because studies showed it helped raise platelet counts in both children and adults with chronic ITP and in adults with liver disease who needed a procedure.",
        "Doptelet was studied in 75 children with ITP who had not improved with earlier treatments. The children were randomly selected to receive either Doptelet or a placebo. Among those taking Doptelet, about 28% reached a stable platelet count without needing additional treatment, and 81% showed improved platelet levels. By the eighth day of treatment, more than half of the children had platelet levels above the target range. In contrast, none of the children receiving the placebo showed similar improvements at any point during the study.",
        "The most common side effects reported during the study were mild and included viral infections, cough, sore throat, and fever. Serious side effects are rare, and no deaths or major bleeding events were reported during the studies."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet was approved because studies showed it helped raise platelet counts in both children and adults with chronic ITP and in adults with liver disease who needed a procedure.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "Doptelet was studied in 75 children with ITP who had not improved with earlier treatments. The children were randomly selected to receive either Doptelet or a placebo. Among those taking Doptelet, about 28% reached a stable platelet count without needing additional treatment, and 81% showed improved platelet levels. By the eighth day of treatment, more than half of the children had platelet levels above the target range. In contrast, none of the children receiving the placebo showed similar improvements at any point during the study.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "The most common side effects reported during the study were mild and included viral infections, cough, sore throat, and fever. Serious side effects are rare, and no deaths or major bleeding events were reported during the studies.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What Do I Need to Know?",
      "content": [
        "Doptelet is taken by mouth as a tablet (for children 6 or older) or as a sprinkle (for younger children) with food. The sprinkle form comes in a capsule that can be opened and mixed with soft food or liquid to make swallowing easier. But the granules should not be crushed or chewed."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet is taken by mouth as a tablet (for children 6 or older) or as a sprinkle (for younger children) with food. The sprinkle form comes in a capsule that can be opened and mixed with soft food or liquid to make swallowing easier. But the granules should not be crushed or chewed.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "Doptelet is used to increase platelet counts to a safe level, but not to normal levels as normalizing levels may raise the risk for blood clots. Blood clots were rare in study patients but did occur in a few adults. Doptelet may interact with other drugs, especially those that affect certain liver enzymes, so make sure to inform your doctor about all medicines and supplements your child takes. The drug is not recommended during pregnancy or breastfeeding. The tablet and sprinkle forms are not equal in strength, so they should not be swapped without a doctor’s guidance.",
        "If your child has ITP and hasn’t improved with other treatments, Doptelet might be an option."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet is used to increase platelet counts to a safe level, but not to normal levels as normalizing levels may raise the risk for blood clots. Blood clots were rare in study patients but did occur in a few adults. Doptelet may interact with other drugs, especially those that affect certain liver enzymes, so make sure to inform your doctor about all medicines and supplements your child takes. The drug is not recommended during pregnancy or breastfeeding. The tablet and sprinkle forms are not equal in strength, so they should not be swapped without a doctor’s guidance.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If your child has ITP and hasn’t improved with other treatments, Doptelet might be an option.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": "What Do I Need to Know?",
      "content": [
        "Doptelet is taken by mouth as a tablet (for children 6 or older) or as a sprinkle (for younger children) with food. The sprinkle form comes in a capsule that can be opened and mixed with soft food or liquid to make swallowing easier. But the granules should not be crushed or chewed."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet is taken by mouth as a tablet (for children 6 or older) or as a sprinkle (for younger children) with food. The sprinkle form comes in a capsule that can be opened and mixed with soft food or liquid to make swallowing easier. But the granules should not be crushed or chewed.",
          "associated_bullets": null
        }
      ]
    },
    {
      "heading": null,
      "content": [
        "Doptelet is used to increase platelet counts to a safe level, but not to normal levels as normalizing levels may raise the risk for blood clots. Blood clots were rare in study patients but did occur in a few adults. Doptelet may interact with other drugs, especially those that affect certain liver enzymes, so make sure to inform your doctor about all medicines and supplements your child takes. The drug is not recommended during pregnancy or breastfeeding. The tablet and sprinkle forms are not equal in strength, so they should not be swapped without a doctor’s guidance.",
        "If your child has ITP and hasn’t improved with other treatments, Doptelet might be an option."
      ],
      "bullets": null,
      "content_blocks": [
        {
          "type": "paragraph",
          "text": "Doptelet is used to increase platelet counts to a safe level, but not to normal levels as normalizing levels may raise the risk for blood clots. Blood clots were rare in study patients but did occur in a few adults. Doptelet may interact with other drugs, especially those that affect certain liver enzymes, so make sure to inform your doctor about all medicines and supplements your child takes. The drug is not recommended during pregnancy or breastfeeding. The tablet and sprinkle forms are not equal in strength, so they should not be swapped without a doctor’s guidance.",
          "associated_bullets": null
        },
        {
          "type": "paragraph",
          "text": "If your child has ITP and hasn’t improved with other treatments, Doptelet might be an option.",
          "associated_bullets": null
        }
      ]
    }
  ],
  "pdfs": [
    "https://doptelet.com/themes/pdf/prescribing-information.pdf"
  ],
  "images": [
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/article_thumbnails/BigBead/piaget_stages_of_development_bigbead/1800x1200_piaget_stages_of_development_bigbead.jpg",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/logos/webmd/web/webmd_logo_white.svg",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/ih-250805-joyani-das-382x382.jpg?resize=51px:51px&output-quality=75",
    "https://img.lb.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/articles/biographies/ih-250805-mary-windle-382x382.jpg?resize=51px:51px&output-quality=75",
    "https://privacy-policy.truste.com/privacy-seal/seal?rid=07326333-3522-463d-81bf-f00fd7171fff",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/layout/shared/tag-registered.png?resize=*:60px",
    "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/oncology/1/footer-images/ad-choice.png",
    "https://img.wbmdstatic.com/vim/live/webmd/consumer_assets/site_images/oncology/1/images/webmd-logo-white.svg",
    "https://sb.scorecardresearch.com/p?c1=2&c2=6035829&cv=3.6&cj=1"
  ],
  "related_links": [],
  "sources": [
    "Doptelet (Sobi) US Prescribing Information, July 2025.",
    "Sobi: “ Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP) .”",
    "Lancet: “ Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study .”"
  ],
  "meta_description": "Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, it is now also approved by the FDA for children aged 1 year or older with chronic immune thrombocytopenia (ITP) who haven’t gotten good responses from earlier treatments.",
  "canonical_url": "https://www.webmd.com/drugs/updates/new-oral-option-children-itp-droptelet",
  "tags": [
    "Health Topics",
    "WebMD"
  ],
  "scrape_timestamp_utc": "2026-01-23T03:36:06.598476Z"
}